David Amsellem
Stock Analyst at Piper Sandler
(5)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
SUPN Supernus Pharmaceuti... | Maintains: Neutral | 36 40 | 45.82 | -12.7% | 13 | Aug 29, 2025 | |
AMGN Amgen | Maintains: Overweight | 328 342 | 280.19 | 22.06% | 5 | Aug 25, 2025 | |
BIIB Biogen | Maintains: Neutral | 115 118 | 141.35 | -16.52% | 2 | Aug 14, 2025 | |
ABBV AbbVie | Assumes: Overweight | 231 | 209.94 | 10.03% | 1 | Aug 12, 2025 | |
AMPH Amphastar Pharma | Maintains: Neutral | 30 25 | 29.26 | -14.56% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 131 121 | 71.23 | 69.87% | 8 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 154 175 | 143.8 | 21.7% | 10 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 9 9 | 8.68 | -2.07% | 2 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 18 | 10.47 | 71.92% | 6 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 37 | 37.75 | -1.99% | 8 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 176 147 | 129.85 | 13.21% | 11 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 65 | 46.72 | 39.13% | 1 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 9 | 9.6 | -6.25% | 3 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 3 4 | 7.77 | -48.52% | 5 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 16 13 | 24.74 | -47.45% | 5 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 14 10 | 10.48 | -4.58% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 23 30 | 19.3 | 55.44% | 10 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 107 132 | 131.87 | 0.1% | 1 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 13 | 15.38 | -15.47% | 5 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 11 | 9.73 | 13.05% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 38 37 | 28.45 | 30.05% | 7 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 68 | 95.2 | -28.57% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 11 6 | 3.65 | 64.38% | 8 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 9 3 | 7.33 | -59.07% | 7 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 42 42 | 26.74 | 57.07% | 7 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 10 | 5.01 | 99.6% | 1 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 21 | 1.13 | 1758.41% | 3 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 113 | 129.29 | -12.6% | 3 | Jan 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 33 45 | 44.96 | 0.09% | 2 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 432 36 | 5.32 | 576.69% | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 72 42 | 35.83 | 17.22% | 3 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 26 17 | n/a | n/a | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 285 | 329.83 | -13.59% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 110 | 116.3 | -5.42% | 5 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 3750 250 | n/a | n/a | 2 | May 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 6 6 | 5.59 | 0.18% | 2 | Apr 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 5 3 | n/a | n/a | 5 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 5 6 | 5.59 | 0.18% | 2 | Feb 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 8 | n/a | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 17 | n/a | n/a | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 9 | n/a | n/a | 4 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Mar 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 2 | Jul 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | n/a | n/a | n/a | 5 | May 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 12 | 2.09 | 474.16% | 1 | Dec 19, 2016 |